Are Newer Potassium Binding Agents Truly Better? Rethinking Sodium Polystyrene Sulfate and Emerging Therapies for Hyperkalemia.
作者信息
Mehta Meera, Auguste Bourne
机构信息
Department of Medicine, University of Toronto, Toronto, ON, Canada.
Department of Nephrology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
出版信息
J Gen Intern Med. 2025 Feb;40(3):516-517. doi: 10.1007/s11606-024-09107-9.
Abstract
摘要
相似文献
1
Are Newer Potassium Binding Agents Truly Better? Rethinking Sodium Polystyrene Sulfate and Emerging Therapies for Hyperkalemia.新型钾结合剂真的更好吗？重新审视聚苯乙烯磺酸钠及高钾血症的新兴疗法。
J Gen Intern Med. 2025 Feb;40(3):516-517. doi: 10.1007/s11606-024-09107-9.
2
Efficacy and safety of potassium binders in the treatment of patients with chronic kidney disease and hyperkalemia.钾结合剂治疗慢性肾脏病伴高钾血症患者的疗效和安全性。
Eur J Pharmacol. 2022 Sep 15;931:175174. doi: 10.1016/j.ejphar.2022.175174. Epub 2022 Aug 12.
3
The role of cation-exchange resins in hyperkalemia management.阳离子交换树脂在高钾血症治疗中的作用。
Med J Armed Forces India. 2025 Jan-Feb;81(1):7-14. doi: 10.1016/j.mjafi.2024.07.001. Epub 2024 Aug 16.
4
Sodium zirconium cyclosilicate versus sodium polystyrene sulfonate for treatment of hyperkalemia in hemodialysis patients: a randomized clinical trial.环硅酸锆钠与聚苯乙烯磺酸钠治疗血液透析患者高钾血症的随机临床试验
BMC Nephrol. 2025 May 6;26(1):227. doi: 10.1186/s12882-025-04129-9.
5
Systematic Review and Meta-Analysis of Patiromer and Sodium Zirconium Cyclosilicate: A New Armamentarium for the Treatment of Hyperkalemia.帕替罗姆和环硅酸锆钠的系统评价与荟萃分析：治疗高钾血症的新武器库
Pharmacotherapy. 2017 Apr;37(4):401-411. doi: 10.1002/phar.1906. Epub 2017 Mar 10.
6
Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD.聚苯乙烯磺酸钠治疗慢性肾脏病轻度高钾血症的随机临床试验
Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2136-42. doi: 10.2215/CJN.03640415. Epub 2015 Nov 17.
7
Potassium binders for chronic hyperkalaemia in people with chronic kidney disease.用于慢性肾脏病患者慢性高钾血症的钾结合剂。
Cochrane Database Syst Rev. 2020 Jun 26;6(6):CD013165. doi: 10.1002/14651858.CD013165.pub2.
8
Patiromer for the treatment of hyperkalemia.聚普瑞锌用于高钾血症的治疗。
Expert Rev Clin Pharmacol. 2020 Jun;13(6):563-570. doi: 10.1080/17512433.2020.1774363. Epub 2020 Jun 8.
9
Therapeutic update on oral potassium exchange resin use in chronic kidney disease patients: a systematic review of randomized controlled clinical trials.口服钾交换树脂在慢性肾脏病患者中的治疗应用更新：一项随机对照临床试验的系统评价。
J Pharm Pharm Sci. 2023 Dec 20;26:11892. doi: 10.3389/jpps.2023.11892. eCollection 2023.
10
Polysulfonate Resins in Hyperkalemia: A Systematic Review.聚磺酸盐树脂治疗高钾血症的系统评价
Can J Kidney Health Dis. 2020 Oct 30;7:2054358120965838. doi: 10.1177/2054358120965838. eCollection 2020.
本文引用的文献
1
Risk of Serious Adverse Gastrointestinal Events with Potassium Binders in Hospitalized Patients: A National Study.住院患者使用钾结合剂发生严重胃肠道不良事件的风险：一项全国性研究。
J Gen Intern Med. 2025 Feb;40(3):518-524. doi: 10.1007/s11606-024-08979-1. Epub 2024 Aug 5.
2
Effectiveness of Patiromer Versus Sodium Zirconium Cyclosilicate for the Management of Acute Hyperkalemia.帕替络尔与硅酸锆钠在急性高钾血症治疗中的疗效比较。
Ann Pharmacother. 2024 Aug;58(8):790-795. doi: 10.1177/10600280231209968. Epub 2023 Nov 12.
3
Sodium polystyrene sulfonate versus sodium zirconium cyclosilicate for the treatment of hyperkalemia in the emergency department.聚苯乙烯磺酸钠与环硅酸锆钠用于急诊科高钾血症治疗的比较
Am J Emerg Med. 2023 Mar;65:59-64. doi: 10.1016/j.ajem.2022.12.043. Epub 2022 Dec 27.
4
Risk of Intestinal Necrosis With Sodium Polystyrene Sulfonate: A Systematic Review and Meta-analysis.聚苯乙烯磺酸钠致肠坏死的风险：一项系统评价与荟萃分析
J Hosp Med. 2021 Aug;16(8):489-494. doi: 10.12788/jhm.3655.
5
Potassium Binders for Hyperkalemia in Chronic Kidney Disease-Diet, Renin-Angiotensin-Aldosterone System Inhibitor Therapy, and Hemodialysis.慢性肾脏病高钾血症的钾结合剂：饮食、肾素-血管紧张素-醛固酮系统抑制剂治疗和血液透析。
Mayo Clin Proc. 2020 Feb;95(2):339-354. doi: 10.1016/j.mayocp.2019.05.019. Epub 2019 Oct 23.
6
Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated With Sodium Polystyrene Sulfonate Use in Patients of Advanced Age.高龄患者使用聚苯乙烯磺酸鈉的严重胃肠道不良事件住院风险。
JAMA Intern Med. 2019 Aug 1;179(8):1025-1033. doi: 10.1001/jamainternmed.2019.0631.
7
Association of prescription of oral sodium polystyrene sulfonate with sorbitol in an inpatient setting with colonic necrosis: a retrospective cohort study.口服聚苯乙烯磺酸钠和山梨醇处方与住院患者结肠坏死的关联：一项回顾性队列研究。
Am J Kidney Dis. 2012 Sep;60(3):409-16. doi: 10.1053/j.ajkd.2012.04.023. Epub 2012 Jun 9.
8
Hyperkalemia.高钾血症
Am Fam Physician. 2006 Jan 15;73(2):283-90.
Zotero 插件